The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 357:418-420 July 26, 2007 Number 4
NextNext

Diabetic Gastroparesis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Camilleri, M.
-PubMed Citation
To the Editor: In his review of diabetic gastroparesis, Camilleri (Feb. 22 issue)1 states that in our clinical trial of exenatide,2 nausea and vomiting led to the "cessation of treatment in about one third of patients." This information is incorrect. Of 282 patients randomly assigned to receive exenatide, 54 withdrew from the study (27 withdrew because of an adverse event, 10 because of protocol violations, 7 because of the patient's decision, 4 because of loss of glucose control, and 1 because of the physician's decision, and 5 were lost to follow-up). As stated in our article, 18 of these patients . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.